Gainers

Intersect ENT, Inc. XENT shares rose 31.17% to $18.22 during Wednesday's pre-market session. The most recent rating by SVB Leerink, on Jun 29, is at Market Perform, with a price target of $14.

Endologix, Inc. ELGX stock moved upwards by 25.12% to $0.39. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.

VBI Vaccines, Inc. VBIV shares rose 19.94% to $4.03.

Concert Pharmaceuticals, Inc. CNCE shares increased by 11.61% to $11.15.

Cocrystal Pharma, Inc. COCP shares rose 11.24% to $1.78. The most recent rating by Noble Capital Markets, on Jun 16, is at Outperform, with a price target of $5.

GenMark Diagnostics, Inc. GNMK shares increased by 10.64% to $17.25. The most recent rating by Needham, on Jul 8, is at Buy, with a price target of $19.

Heat Biologics, Inc. HTBX shares rose 9.07% to $0.97.

BioCryst Pharmaceuticals, Inc. BCRX shares moved upwards by 9.05% to $5.90. According to the most recent rating by BTIG, on Jun 17, the current rating is at Neutral.

CHF Solutions, Inc. CHFS shares increased by 8.87% to $0.65.

InflaRx, Inc. IFRX stock moved upwards by 8.20% to $5.54. The most recent rating by BTIG, on Jun 17, is at Buy, with a price target of $12.

 

Losers

VIVUS, Inc. VVUS shares declined 35.61% to $0.52 during Wednesday's pre-market session.

Hepion Pharmaceuticals, Inc. HEPA shares declined 10.68% to $3.68.

89bio, Inc. ETNB shares decreased by 6.96% to $30.75. The most recent rating by Chardan Capital, on Jul 7, is at Buy, with a price target of $58.

Acasti Pharma, Inc. ACST stock decreased by 5.28% to $0.68. The most recent rating by B. Riley FBR, on Jul 6, is at Buy, with a price target of $2.

AEterna Zentaris, Inc. AEZS stock declined 5.19% to $0.49.

HealthEquity, Inc. HQY stock declined 4.91% to $55.25. The most recent rating by Cantor Fitzgerald, on Jun 3, is at Overweight, with a price target of $70.

Viveve Medical, Inc. VIVE shares decreased by 4.84% to $0.61.

China SXT Pharmaceuticals, Inc. SXTC stock decreased by 4.65% to $0.54.

Diffusion Pharmaceuticals, Inc. DFFN stock fell 4.42% to $0.88.

Aclaris Therapeutics, Inc. ACRS stock fell 3.96% to $1.70.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!